You are here :
Home
Healthcare
Payment Link for Sterlitech Corporation - Track etched Membrane Market & Pharmaceutical Filtration Market
Drug formulations
Global ATC Market Research Report
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Asian Conjugate Vaccines Market The Asian conjugate animal vaccine market is mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $34.2 million in 2013 and is expected to reach $62.6 million by 2018, at a CAGR of 12.8% during the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac. |
Upcoming |
|
|
North American Recombinant vaccines Market The North American Recombinant Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $118.1 million in 2013 and expected to be $151.5 million by 2018 at a CAGR of 5.1%. Recombinant Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac. |
Upcoming |
|
|
European Recombinant vaccines Market The European Recombinant Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $140.2 million in 2013 and expected to be $190 million by 2018 at a CAGR of 6.3%. Recombinant Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac. |
Upcoming |
|
|
North American DNA vaccines Market The North American DNA animal vaccine market, mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans, was valued at $45.6 million in 2013 and is expected to reach $63.9 million by 2018, at a CAGR of 7.0% during the forecast period. The report on this market analyzes it under six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac. |
Upcoming |
|
|
European DNA vaccines Market The European DNA animal vaccine market, mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans, was valued at $54.2 million in 2013 and is expected to reach $80.2 million by 2018, at a CAGR of 8.2% during the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac. |
Upcoming |
|
|
Asian DNA vaccines Market The Asian DNA animal vaccine market, mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans, was valued at $24.2 million in 2013 and is expected to reach $47.6 million by 2018, at a CAGR of 14.5%. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac. |
Upcoming |
ATC
